Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deal Watch: AstraZeneca Offloads US Anesthesiology Portfolio To Aspen

Executive Summary

Merck adds to its immuno-oncology R&D heft with purchase of Rigontec, while Allergan will collaborate with Lyndra to produce once-weekly drugs for Alzheimer’s disease.


Related Content

Finance Watch: Bitcoin For Biopharma? Agenus Gives BEST A Shot
AZ Cashes In On No-Longer Core Nexium
Start-Up Quarterly Statistics: Fundraising Fell, But Deal-Making Rose In Q3
Clinigen Takes Aim At Unlicensed-To-Licensed Strategy With Quantum Buy
Achillion Keeps Focus On Complement Factor D Inhibitors As J&J Exits HCV
Boehringer Taps Gubra For Early-Stage Obesity Deal
Allergan Shifts Restasis Patents To Native American Tribe To Invoke Immunity From IPR
Bicycle Partners With Biogen Spinout Against Rare Blood Disorders
Aspen Acquires AstraZeneca Anesthetics Portfolio Ex-US


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts